Concepedia
Statistics
Publications
19
Citations
625
H-Index
14
Active since
1988
Affiliations
Pfizer (United States)(Current)
Johns Hopkins University
Wilmington University
New Frontier
Claudia R. Turner is an author at Pfizer (United States) specializing in immunology, pharmacology, and hypersensitivity.
Publications per year
1988–1998
In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.
Claudia R. Turner, R Breslow, Maryrose J. Conklyn et al. · Journal of Clinical Investigation · 1996 · 102 citations · Full text
Medicine, Immunology, Pharmacology +11
Effects of Rolipram on Responses to Acute and Chronic Antigen Exposure in Monkeys
Claudia R. Turner, Catharine J. Andresen, William Smith et al. · American Journal of Respiratory and Critical Care Medicine · 1994 · 96 citations
Medicine, Immunology, Pharmacology +13
Intratracheal aerosolization of endotoxin in the rat: a model of the adult respiratory distress syndrome (ARDS)
Eric B. Wheeldon, M. E. Walker, Dennis J. Murphy et al. · Laboratory Animals · 1992 · 62 citations · Full text
Medicine, Immunology, Toxicology +17
In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
Victoria L. Cohan, Henry J. Showell, D A Fisher et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 54 citations
Medicine, Medicinal Chemistry, Pharmacology +14
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
John B. Cheng, J. W. Watson, Christopher J. Pazoles et al. · PubMed · 1997 · 37 citations
Life Sciences, Biochemistry, Pharmacology +14
1–5 of 19